Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale Chief Legal Officer sold 11,040 shares at $1.01 ($11,150)
  2. 4 Open-market sale President & CEO sold 23,774 shares at $1.01 ($24,012)
  3. 5 Insider Annual Insider Trading Report
  4. 5 Insider Annual Insider Trading Report
  5. 5 Insider Annual Insider Trading Report
  6. 5 Insider Annual Insider Trading Report
  7. 5 Insider Annual Insider Trading Report
  8. 4 Open-market sale Chief Legal Officer sold 49,962 shares at an average $0.90 ($44,800)
  9. 4 Open-market sale Chief R&D Officer sold 51,115 shares at $0.94 ($48,048)
  10. 4 Open-market sale President & CEO sold 132,030 shares at an average $1.00 ($131,650)
  11. 4 Grant or award Chief R&D Officer acquired 135,000 shares (grant or award)
  12. 4 Grant or award Chief Legal Officer acquired 165,938 shares (grant or award)
  13. 4 Grant or award President & CEO acquired 410,625 shares (grant or award)
  14. 4 Open-market sale Chief R&D Officer sold 7,785 shares at $1.01 ($7,863)
  15. 4 Open-market sale Chief Legal Officer sold 6,407 shares at $1.01 ($6,471)
  16. 4 Open-market sale President & CEO sold 16,278 shares at $1.01 ($16,441)
  17. 4 Open-market sale Chief R&D Officer sold 6,866 shares at $1.28 ($8,788)
  18. 4 Open-market sale Chief Legal Officer sold 5,651 shares at $1.28 ($7,233)
  19. 4 Open-market sale President & CEO sold 14,881 shares at $1.28 ($19,048)
  20. 4 Planned sale Director sold 19,500 shares at $1.20 ($23,400)

Page 3 of 49 · 968 filings